Most patients with ovarian cancer (OvCA) present peritoneal disseminated disease at the
time of diagnosis. During peritoneal metastasis, cancer cells detach from the primary tumor …

Ovarian cancer is the most lethal gynecologic malignancy, and patient prognosis has not
improved significantly over the last several decades. In order to improve therapeutic …

Epithelial ovarian cancer (EOC) is a leading cause of cancer-related death in women. Late-
stage diagnosis with significant tumor burden, accompanied by recurrence and …

Peritoneal metastases are a common form of tumor cell dissemination in gastrointestinal
malignancies. Peritoneal metastatic disease (PMD) is associated with severe morbidity and …

Epithelial ovarian cancer (EOC) is considered the deadliest gynecological disease and is
normally diagnosed at late stages, at which point metastasis has already occurred …

Albumin is a remarkable carrier protein with multiple cellular receptor and ligand binding
sites, which are able to bind and transport numerous endogenous and exogenous …

Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive solid tumor, with
a 5-year mortality rate of~ 50%. The development of immunotherapies has improved the …

Peritoneal metastasis (PM) is most frequent in gastric cancer (GC) and cancer-associated
fibroblasts (CAFs) play a critical role in this process. However, the concrete mechanism of …

Ovarian cancer (OvCa), a lethal gynecological malignancy, disseminates to the peritoneum.
Mesothelial cells (MCs) act as barriers in the abdominal cavity, preventing the adhesion of …

An intact mesothelium serves as a protective barrier to inhibit peritoneal carcinomatosis.
Cancer‐derived exosomes can mediate directional tumor metastasis; however, little is …